Brief: Bioarctic Says Leqembi Approved For IV Maintenance Treatment In United Kingdom
13/11/2025 23:31
Nov 13 (Reuters) - BioArctic AB BIOAb.ST: BIOARCTIC AB - LEQEMBI® APPROVED FOR IV MAINTENANCE TREATMENT IN UNITED KINGDOM Source text: ID:nWkr182mch Further company coverage: [BIOAb.ST] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln